Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M798Revenue $M24.1Net Margin (%)-80.0Z-Score12.1
Enterprise Value $M636EPS $-0.5Operating Margin %-80.7F-Score3
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-80.0Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %-1.7Quick Ratio8.9Cash flow > EarningsY
Price/Sales20.25-y EBITDA Growth Rate %-1.9Current Ratio8.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-14.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-17.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M68.4ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJean-Marie Eveillard 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 11.67-19%Add 34.1%536,380
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 11.67-39%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 11.6717%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 11.6734%Add 41.45%424,350
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 11.6731%New holding, 300000 sh.300,000
SGMOJean-Marie Eveillard 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 11.67107%Sold Out0
SGMOJean-Marie Eveillard 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 11.6799%New holding, 470 sh.470
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 11.6785%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 11.67178%New holding, 260600 sh.260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 11.67185%Sold Out0
SGMOJean-Marie Eveillard 2008-12-31 Buy 0.01%$2.13 - $7.81
($4.6)
$ 11.67154%New holding, 288000 sh.288,000
SGMOJean-Marie Eveillard 2008-06-30 Sold Out $9.07 - $13.37
($11.3)
$ 11.673%Sold Out0
SGMOJean-Marie Eveillard 2007-12-31 Buy 0.01%$12.81 - $18.5
($15.1)
$ 11.67-23%New holding, 50000 sh.50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGMO Jean-Marie Eveillard 2014-09-30536,3800.780.01
SGMO - CALLJean-Marie Eveillard 2014-09-304,0000.010
Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2014-11-17Sell25,000$11.233.92view
LARSON JOHN WILLIAMDirector 2014-11-12Sell10,000$12-2.75view
Wolff Henry WardExec VP & CFO 2014-11-10Sell2,000$11.372.64view
ANDO DALE GVP, Therapeutic Dev. & CMO 2014-11-05Sell15,000$11.352.82view
Gregory Philip DSVP of Research & CSO 2014-11-03Sell15,000$11.91-2.02view
LARSON JOHN WILLIAMDirector 2014-10-28Sell10,000$12.02-2.91view
LANPHIER EDWARD O IIPresident & CEO 2014-10-15Sell25,000$10.4911.25view
Wolff Henry WardExec VP & CFO 2014-10-10Sell2,000$10.115.54view
ANDO DALE GVP, Therapeutic Dev. & CMO 2014-10-06Sell15,000$10.728.86view
Gregory Philip DSVP of Research & CSO 2014-10-01Sell15,000$10.88.06view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 


    More From Other Websites
    Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo... Nov 19 2014
    Sangamo BioSciences Presents Study At Society For Neuroscience Meeting Demonstrating In Vivo... Nov 19 2014
    Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
    Sangamo BioSciences Announces Presentation at the 26th Annual Piper Jaffray Healthcare Conference Nov 18 2014
    Insider Trading Alert - CCOI, CRM And SGMO Traded By Insiders Nov 14 2014
    Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for... Nov 10 2014
    Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for... Nov 10 2014
    SANGAMO BIOSCIENCES INC Financials Nov 04 2014
    10-Q for Sangamo BioSciences, Inc. Oct 30 2014
    Sangamo Biosciences (SGMO) Upgraded From Sell to Hold Oct 30 2014
    SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report Oct 28 2014
    Sangamo tops Street 3Q forecasts Oct 22 2014
    Sangamo tops Street 3Q forecasts Oct 22 2014
    Sangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today Oct 22 2014
    Sangamo BioSciences Reports Third Quarter 2014 Financial Results Oct 22 2014
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Oct 22 2014
    Sangamo BioSciences Reports Third Quarter 2014 Financial Results Oct 22 2014
    Q3 2014 Sangamo BioSciences Inc Earnings Release - After Market Close Oct 22 2014
    Will Sangamo (SGMO) Incur Wider-than-Expected Q3 Loss? Oct 20 2014
    Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific... Oct 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK